Calyxo Raises $32.7 Million In Series C Financing To Support Novel Approach To Treating Kidney Stones
Calyxo Raises $32.7 Million In Series C Financing To Support Novel Approach To Treating Kidney Stones
07/06/22, 4:02 PM
Location
pleasantonMoney raised
$32.7 million
Round Type
series c
Calyxo, Inc., a medical device company focused on improving care for patients with kidney stones by delivering next generation treatment solutions, has announced the closing of a $32.7 million Series C financing round led by Questa Capital and CRG.
Company Info
Location
pleasanton, california, united states
Additional Info
Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones by delivering paradigm-shifting solutions that enable urologists to safely, effectively and efficiently achieve unrivaled clinical outcomes. Learn more at calyxoinc.com.